Literature DB >> 27882078

Debridement in chronic osteomyelitis with benign osteopetrosis: A case report.

Yu-Ping Liu1, Xiang-Hua Lin2, Man-Yun Yan3, Bao-Quan Lin3, Ming-Ying Zhuo3.   

Abstract

Osteopetrosis is a rare bone disease caused by metabolic imbalances as a result of genetic mutations. For instance, autosomal dominant osteopetrosis is caused by a missense mutation of the C1CN7 gene. This was first reported in 1904 and is thought to be caused by osteoclastic dysfunction and an impaired bone resorption ability. An accumulation of cortical bone mass during the remodeling of the medullary bone may increase the bone density and give rise to a hard marble consistency. Osteopetrosis can be divided into benign and malignant forms; however, no curative treatment exists for benign osteopetrosis. The management of complications, such as chronic osteomyelitis and fractures, serves a key role in influencing the patient survival rates. Previous studies have demonstrated that a combined treatment of hyperbaric oxygen (HBO) lavage for debridement of the necrotic region and high-dose systemic antibiotics may be effective in the management of osteopetrosis. The present study reported a case of chronic mandible osteomyelitis and fistula occurring in association with maxillary sinusitis, who was successfully treated by through nasal endoscopy, using repeated flushing and cleaning every 2 weeks as a form of debridement, in the absence of high-dose antibiotics and HBO.

Entities:  

Keywords:  benign osteopetrosis; chronic osteomyelitis; debridement

Year:  2016        PMID: 27882078      PMCID: PMC5103689          DOI: 10.3892/etm.2016.3706

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  9 in total

Review 1.  Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects.

Authors:  J Bollerslev
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.

Authors:  O D Bénichou; J D Laredo; M C de Vernejoul
Journal:  Bone       Date:  2000-01       Impact factor: 4.398

3.  Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis.

Authors:  J Bollerslev; P E Andersen
Journal:  Bone       Date:  1988       Impact factor: 4.398

4.  Albers-Schönberg disease (osteopetrosis). Report of a case and review of the literature.

Authors:  N H Smith
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1966-12

5.  Autosomal dominant type I osteopetrosis is related with iatrogenic fractures in arthroplasty.

Authors:  Ruud P van Hove; Tjitte de Jong; Peter A Nolte
Journal:  Clin Orthop Surg       Date:  2014-11-10

6.  Osteomyelitis complicating osteopetrosis--a case report.

Authors:  K J Juggins; G M Walton; M Patel
Journal:  Dent Update       Date:  2001-12

7.  Osteomyelitis of the mandible in a patient with osteopetrosis. Case report and review of the literature.

Authors:  Carlos Moreno García; María Asunción Pons García; Raúl González García; Florencio Monje Gil
Journal:  J Maxillofac Oral Surg       Date:  2011-04-20

8.  [Juvenile osteomyelitis and osteopetrosis. A case report].

Authors:  M A Battaglia; P Drigo; A M Laverda; A Antolini; M Venuleo; A Miotti; L Pavone
Journal:  Minerva Stomatol       Date:  1991-03

Review 9.  Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton.

Authors:  Amélie E Coudert; Marie-Christine de Vernejoul; Maurizio Muraca; Andrea Del Fattore
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

  9 in total
  2 in total

1.  Surgical management of chronic osteomyelitis with benign osteopetrosis: A case report.

Authors:  Mohamed Raiteb; Sanaa Elmrini; Faiçal Slimani
Journal:  Ann Med Surg (Lond)       Date:  2021-04-20

2.  Extensive maxillary osteomyelitis following tooth extraction in a patient with osteopetrosis.

Authors:  Kumar Nilesh
Journal:  BMJ Case Rep       Date:  2020-06-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.